Intuitive Surgical (FRA:IUI) Current Deferred Revenue: €477 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IUI Intuitive Surgical Inc FRA:IUI
76 GF Score
Price €10.90
GF Value €19.01
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Intuitive Surgical Current Deferred Revenue?

Intuitive Surgical FRA:IUI -0.91% 76 Current Deferred Revenue is €477 Mil as of Jun. 2026. GuruFocus rates FRA:IUI with a GF Score™ of 76/100 and a GF Value™ of €19.01 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Intuitive Surgical's current deferred revenue for the quarter that ended in Jun. 2026 was €477 Mil.

Intuitive Surgical Current Deferred Revenue Related Terms

Intuitive Surgical Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Intuitive Surgical's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intuitive Surgical Current Deferred Revenue Chart

Intuitive Surgical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 333.82 375.05 409.07 447.70 432.72

Intuitive Surgical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 433.41 418.42 432.72 483.97 476.88
FRA:IUI
76GF Score
Intuitive Surgical Inc FRA:IUI
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of €477 Mil mean?
Intuitive Surgical (FRA:IUI) has a Current Deferred Revenue of €477 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Intuitive Surgical and its competitors.
Is Intuitive Surgical's Current Deferred Revenue too high?
Intuitive Surgical's current Current Deferred Revenue is €477 Mil. Overall, Intuitive Surgical has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intuitive Surgical's Current Deferred Revenue compare to BDX and MDLN?
Intuitive Surgical's Current Deferred Revenue of €477 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Devices & Instruments company?
A good Current Deferred Revenue depends on the Medical Devices & Instruments industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Intuitive Surgical and its competitors. Intuitive Surgical's current Current Deferred Revenue is €477 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intuitive Surgical stock overvalued right now?
Based on GuruFocus' analysis, Intuitive Surgical (FRA:IUI) is currently considered Significantly Undervalued. The stock's GF Value™ is €19.01, compared to a current price of €10.90 — trading 42.7% below its estimated fair value. The current Current Deferred Revenue is €477 Mil. Intuitive Surgical's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Intuitive Surgical (FRA:IUI), the current Current Deferred Revenue is €477 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intuitive Surgical (FRA:IUI) Overvalued in 2026?

Based on GuruFocus' analysis, Intuitive Surgical stock appears to be undervalued. The current stock price of €10.90 is trading 42.7% below its estimated GF Value™ of €19.01. GuruFocus considers Intuitive Surgical to be Significantly Undervalued.

Key valuation signals for FRA:IUI:

  • Current Deferred Revenue: €477 Mil
  • GF Value™: €19.01 vs. price of €10.90 (42.7% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the FRA:IUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intuitive Surgical Business Description

Address 1020 Kifer Road, Sunnyvale, CA, USA, 94086
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
76GF Score

Get the complete analysis for FRA:IUI

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.90
Price
€19.01
GF Value